Alternative Antiepileptic Medications for Pregnant Patients on Oxcarbazepine

Risk Assessment and Management

• Oxcarbazepine is classified as a medication that may increase risk during pregnancy, with guidelines listing it among anticonvulsants that require consideration for alternative therapy, as recommended by the Centers for Disease Control and Prevention 1, 2
• The American College of Obstetricians and Gynecologists recommends assessing seizure control and pregnancy status, determining gestational age and current seizure control on oxcarbazepine 3

Recommended Alternatives and Monitoring

• Levetiracetam does not require the same precautions as enzyme-inducing antiepileptic drugs, according to the Centers for Disease Control and Prevention 1
• The European Respiratory Society suggests that increased monitoring of drug levels may be necessary as pregnancy can alter pharmacokinetics 4
• The American Heart Association recommends adjusting dosage as needed based on clinical response and serum levels 5

Special Considerations

• The European Respiratory Society states that both lamotrigine and levetiracetam can be used during breastfeeding with appropriate monitoring of the infant 4
• The National Institute of Neurological Disorders and Stroke recommends considering HLA-B*15:02 screening before initiating certain antiepileptic drugs, particularly in patients of Asian descent 3

Common Pitfalls to Avoid

• The National Institute of Neurological Disorders and Stroke advises against abrupt discontinuation of antiepileptic medication as this may precipitate status epilepticus 3
• The European Respiratory Society warns that pregnancy can alter drug metabolism, requiring more frequent monitoring and potential dose adjustments 4